Treatment with a CRH-R1 antagonist prevents stress-induced suppression of the central neural drive to the reproductive axis in female macaques

American Journal of Physiology - Endocrinology and Metabolism

Volumn 300, Issue 1, 2011, Pages

  Herod, S M ^a,e   Poh, C R ^b   Cameron, J L ^a,c,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b DUQUESNE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e AZUSA PACIFIC UNIVERSITY   (United States)

Author keywords

Antalarmin; Corticotropin releasing hormone; Corticotropin releasing hormone receptor 1; Cortisol; Reproduction

Indexed keywords

ANTALARMIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; HYDROCORTISONE; LUTEINIZING HORMONE;

ANIMAL EXPERIMENT; ANOVULATION; ARTICLE; CONTROLLED STUDY; DIET; FEMALE; HYDROCORTISONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MACACA; MENSTRUAL CYCLE; MENTAL STRESS; METABOLIC STRESS; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REPRODUCTION; SOCIAL STRESS; STRESS;

ANIMALS; ANOVULATION; ANTI-ANXIETY AGENTS; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; DIET; FEMALE; HYDROCORTISONE; INFERTILITY, FEMALE; INJECTIONS, INTRAVENOUS; LUTEINIZING HORMONE; MACACA FASCICULARIS; PYRIMIDINES; PYRROLES; RANDOM ALLOCATION; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SOCIAL ENVIRONMENT; STRESS, PSYCHOLOGICAL;

EID: 78650786843     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00224.2010     Document Type: Article

References (56)

1. Ayala AR, Pushkas J, Higley JD, Ronsaville D, Gold PW, Chrousos GP, Pacak K, Calis KA, Gerald M, Lindell S, Rice KC, Cizza G. Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm. J Clin Endocrinol Metab 89: 5729-5737, 2004. (Pubitemid 39518466)
2. Berga SL, Daniels TL, Giles DE. Women with functional hypothalamic amenorrhea but not other forms of anovulation display amplified cortisol concentrations. Fertil Steril 67: 1024-1030, 1997.
3. Berga SL, Mortola JF, Girton L, Suh B, Laughlin G, Pham P, Yen SSC. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 68: 301-308, 1989.
4. Bethea CL, Centeno ML, Cameron JL. Neurobiology of stress-induced reproductive dysfunction in female macaques. Mol Neurobiol 38: 199-230, 2008.
5. Bethea CL, Pau FK, Fox S, Hess DL, Berga SL, Cameron JL. Sensitivity to stress-induced reproductive dysfunction linked to activity of the serotonin system. Fertil Steril 83(1): 148-55, 2005. (Pubitemid 40094794)
6. Bethea CL, Streicher JM, Mirkes S, Sanchez RL, Reddy AP, Cameron JL. Serotonin-related gene expression in female monkeys with individual sensitivity to stress. Neuroscience 132: 151-166, 2005.
7. Biller BM, Federoff HJ, Koenig JI, Klibanski A. Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. J Clin Endocrinol Metab 70: 311-317, 1990. (Pubitemid 120009824)
8. Bomba M, Gambera A, Bonini L, Peroni M, Neri F, Scagliola P, Nacinovich R. Endocrine profiles and neuropsychologic correlates of functional hypothalamic amenorrhea in adolescents. Fertil Steril 87: 876-885, 2007.
9. Bornstein SR, Webster EL, Torpy DJ, Richman SJ, Mitsiades N, Igel M, Lewis DB, Rice KC, Joost HG, Tsokos M, Chrousos GP. Chronic effect of a nonpeptide corticotropin-releasing hormone type 1 receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. Endocrinology 139: 1546-1555, 1998.
10. Broadbear JH, Winger G, Rivier JE, Rice KC, Woods JH. Corticotropin- releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys. Neuropsychopharmacology 29: 1112-1121, 2002.
11. Brundu B, Loucks TL, Adler LJ, Cameron JL, Berga SL. Increased cortisol in the cerebrospinal fluid of women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 91: 1561-1565, 2006.
12. Cameron JL. Stress and behaviorally induced reproductive dysfunction in primates. Semin Reprod Endocrinol 15: 37-45, 1997.
13. Cameron JL. Reproductive dysfunction in primates, behaviorally induced. In: Encyclopedia of Stress, edited by Fink G. New York: Academic, 2000, p. 366-372.
14. Cameron JL, Bridges MW, Graham RE, Bench L, Berga SL, Matthews K. Basal heartrate predicts development of reproductive dysfunction in response to psychological stress (Abstract PI-76). The Endocrine Society Program and Abstracts 80th Annual Meeting, New Orleans, LA, June 24-27, 1998.
15. Cameron JL, Nosbisch C. Suppression of pulsatile luteinizing hormone and testosterone secretion during short term food restriction in the adult male rhesus monkey (Macaca mulatta). Endocrinology 128: 1532-1540, 1991.
16. Centeno ML, Sanchez RL, Cameron JL, Bethea CL. Hypothalamic expression of serotonin 1A, 2A and 2C receptor and GAD67 mRNA in female cynomolgus monkeys with different sensitivity to stress. Brain Res 1142: 1-12, 2007. (Pubitemid 46413204)
17. Centeno ML, Sanchez RL, Reddy AP, Cameron JL, Bethea CL. Corticotropin-releasing hormone and pro-opiomelanocortin gene expression in female monkeys with differences in sensitivity to stress. Neuroendocrinology 86: 277-288, 2007. (Pubitemid 350136510)
18. Chan EC, Falconer J, Madsen G, Rice KC, Webster EL, Chrousos GP, Smith R. A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep. Endocrinology 139: 3357-3360, 1998. (Pubitemid 28512369)
19. Chen YP. International Patent No. WO94/13676, June 23, 1994.
20. Coste SC, Murray SE, Stenzel-Poore MP. Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides 22: 733-741, 2001.
21. Couzinet B, Young J, Brailly S, Le Bouc Y, Chanson P, Schaison G. Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clin Endocrinol (Oxf) 50: 229-235, 1999. (Pubitemid 29100011)
22. Crowley WF Jr, Filicori M, Spratt DI, Santoro NF. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 41: 473-531, 1985.
23. Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF, Licinio J, Wong ML, Chrousos GP, Webster E, Gold PW. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 140: 79-86, 1999. (Pubitemid 29011144)
24. French JA, Fite JE, Jensen H, Oparowski K, Rukstalis MR, Fix H, Jones B, Maxwell H, Pacer M, Power ML, Schulkin J. Treatment with the CRH-1 antagonist antalarmin reduces behavioral and endocrine responses to social stressors in marmosets (Callithrix kuhlii). Am J Primatol 69: 877-889, 2007.
25. Giles DE, Berga SL. Cognitive and psychiatric correlates of functional hypothalamic amenorrhea: a controlled comparison. Fertil Steril 60: 486-492, 1993.
26. Grakalic I, Schindler CW, Baumann MH, Rice KC, Riley AL. Effects of stress modulation on morphine-induced conditioned place preferences and plasma corticosterone levels in Fischer, Lewis, and Sprague-Dawley rat strains. Psychopharmacology (Berl) 189: 277-286, 2006.
27. Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S, Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP, McCann SM, Suomi SJ, Higley JD, Gold PW. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA 97: 6079-6084, 2000.
28. Herod SM, Centeno ML, Bethea CL, Cameron JL. Evidence for a non-neuroendocrine role of corticotropin-releasing hormone (CRH) in female cynomolgus monkeys sensitive to stress-induced reproductive dysfunction (Abstract No. 283.3). Program of the 38th Annual Meeting of the Society for Neuroscience, Washington, DC, 2008.
29. Herod SM, Dettmer AM, Novak MA, Meyer JS, Cameron JL. Sensitivity to stress-induced reproductive dysfunction is associated with a selective but not a generalized increase in activity of the adrenal axis. Am J Physiol Endocrinol Metab (First published October 19, 2010). doi: 10.1152/ajpendo.00224.2010.
30. Hsin LW, Tian X, Webster EL, Coop A, Caldwell TM, Jacobson AE, Chrousos GP, Gold PW, Habib KE, Ayala A, Eckelman WC, Contoreggi C, Rice KC. CHR-R1 receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists. Bioorg Med Chem 10: 175-183, 2002.
31. Jensen JT, Zelinski MB, Stanley JE, Fanton JW, Stouffer RL. The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation in the naturally selected dominant follicle in rhesus macaques. Contraception 77: 303-307, 2008.
32. Kalantaridou SN, Makrigiannakis A, Zoumakis E, Chrousos GP. Reproductive functions of corticotropin-releasing hormone. Research and potential clinical utility of antalarmins (CRH receptor type 1 antagonists). Am J Reprod Immunol 51: 269-274, 2004.
33. Khoury SA, Reame NE, Kelch RP, Marshall JC. Diurnal patterns of pulsatile luteinizing hormone secretion in hypothalamic amenorrhea: reproducibility and responses to opiate blockade and an alpha 2-adrenergic agonist. J Clin Endocrinol Metab 64: 755-762, 1986.
34. Kondoh Y, Uemura T, Murase M, Yokoi N, Ishikawa M, Hirahara F. A longitudinal study of disturbances of the hypothalamic-pituitary-adrenal axis in women with progestin-negative functional hypothalamic amenorrhea. Fertil Steril 7: 748-752, 2001.
35. Laughlin GA, Dominguez CE, Yen SS. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 83: 25-32, 1998.
36. Lindahl MS, Olovsson M, Nyberg S, Thorsen K, Olsson T, Poromaa IS. Increased cortisol responsivity to adrenocorticotropic hormone and low plasma levels of interleukin-1 receptor antagonist in women with functional hypothalamic amenorrhea. Fertil Steril 87: 136-142, 2007.
37. Liu JH. Hypothalamic amenorrhea: clinical perspectives, pathophysiology, and management. Am J Obstet Gynecol 163: 1732-1736, 1990.
38. Luton J, Thiebolt P, Valcke J, Mahoudeau JA, Bricaire H. Reversible gonadotropin deficiency in male Cushing's disease. J Clin Endocrinol Metab 45: 488-495, 1977. (Pubitemid 8194485)
39. Makino S, Hashimoto K, Gold PW. Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress. Pharmacol Biochem Behav 73: 147-158, 2002. (Pubitemid 34667027)
40. Makrigiannakis A, Zoumakis E, Kalantaridou S, Coutifaris C, Margioris AN, Coukos G, Rice KC, Gravanis A, Chrousos GP. Corticotroopin-releasing hormone promotes blastocyst implantation and early maternal tolerance. Nat Immunol 2: 1018-1024, 2001.
41. Marcus MD, Loucks TL, Berga SL. Psychological correlates of functional hypothalmic amenorrhea. Fertil Steril 76: 310-316, 2001.
42. Meczekalski B, Tonetti A, Monteleone P, Bernardi F, Luisi S, Stomati M, Luisi M, Petraglia F, Genazzani AR. Hypothalamic amenorrhea with normal body weight: ACTH, allopregnanolone and cortisol responses to corticotropin-releasing hormone test. Eur J Endocrinol 142: 280-285, 2000.
43. Merriam GR, Wachter KW. Algorithms for the study of episodic hormone secretion. Am J Physiol Endocrinol Metab 243: E310-E318, 1982.
44. Myers DA, Gibson M, Schulkin J, Greenwood Van-Meerveld B. Corticosterone implants to the amygdala and type 1 CRH receptor regulation: effects on behavior and colonic sensitivity. Behav Brain Res 161: 39-44, 2005.
45. Nielsen DM, Carey GJ, Gold LH. Antidepressant-like activity of corticotropin- releasing factor type-1 receptor antagonists in mice. Eur J Pharmacol 499: 135-146, 2004.
46. Pohl CR, Knobil E. The role of the central nervous system in the control of ovarian function in higher primates. Annu Rev Physiol 44: 583-593, 1982.
47. Pohl CR, Richardson DW, Hutchison JS, Germak JA, Knobil E. Hypophysiotropic signal frequency and the functioning of the pituitaryovarian system in the rhesus monkey. Endocrinology 112: 2076-2080, 1983.
48. Reame NE, Sauder SE, Case GD, Kelch RP, Marshall JC. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation. J Clin Endocrinol Metab 61: 851-858, 1985.
49. Rogers CJ, Brissette-Storkus CS, Chambers WH, Cameron JL. Acute stress impairs NK cell adhesion and cytotoxicity through CD2, but not LFA-1. J Neuroimmunol 99: 230-241, 1999.
50. Suh BY, Liu JH, Berga SL, Quigley ME, Laughlin GA, Yen SS. Hypercortisolism in patients with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 66: 733-739, 1988.
51. Vogeser M, Engelhardt D, Jacob K. Comparison of two automated adrenocorticotropic hormone assays. Clin Chem 46: 1998-2000, 2000.
52. Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC, Chrousos GP. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin- releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137: 5747-5750, 1996.
53. Williams NI, Berga SL, Cameron JL. Synergism between psychosocial and metabolic stressors: impact on reproductive function in cynomolgus monkeys. Am J Physiol Endocrinol Metab 293: E270-E276, 2007.
54. Williams NI, Caston-Balderrama AL, Helmreich DL, Parfitt DB, Nosbisch C, Cameron JL. Longitudinal changes in reproductive hormones and menstrual cyclicity in cynomolgus monkeys during strenuous exercise training: abrupt transition to exercise-induced amenorrhea. Endocrinology 142: 2381-2389, 2001.
55. Williams NI, Helmreich DL, Parfitt DB, Caston-Balderrama A, Cameron JL. Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab 86: 5184-5193, 2001.
56. Wong ML, Webster EL, Spokes H, Phu P, Ehrhart-Bornstein M, Bornstein S, Park CS, Rice KC, Chrousos GP, Licinio J, Gold PW. Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress. Life Sci 65: PL53-PL58, 1999.